Inhibition of RUNX1 slows the progression of pulmonary hypertension by targeting CBX5. Biomol Biomed [Internet]. 2025 Jan. 14 [cited 2025 Apr. 16];25(2):472–481. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10720